GP's hep B blitz in misusers
GPs are too cautious in their use of ß-blockers and ACE inhibitors and need to be updated on the latest evidence on treating heart failure, a new Europe-wide trial concludes.
Only 7-29 per cent of
GPs achieved target doses of ß-blockers and 18-30 per cent hit target doses for ACE inhibitors, according to the study, published in last month's European Journal of Heart Failure.
The SHAPE trial analysed the prescribing of 3,000 GPs from nine European countries, including the UK.
It also found 75 per cent of GPs diagnosed heart failure on the basis of signs and symptoms alone, although 64 per cent believed an echocardiogram was needed for accurate diagnosis.
And there was evidence that GPs treated patients differently according to their age.